True or false? Challenges and recent highlights in the development of aspirin prodrugs
Authors:
- 1 April 2020
- journal article
- review article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 192, 112200
Abstract
No abstract availableKeywords
Funding Information
- School of Chemistry, Cardiff University
This publication has 72 references indexed in Scilit:
- Prodrugs of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), More Than Meets the Eye: A Critical ReviewInternational Journal of Molecular Sciences, 2012
- The role of aspirin in cancer preventionNature Reviews Clinical Oncology, 2012
- Efficacy and Safety of COX-2 Inhibitors in the Clinical Management of Arthritis: Mini ReviewISRN Pharmacology, 2011
- The novel phospho‐non‐steroidal anti‐inflammatory drugs, OXT‐328, MDC‐22 and MDC‐917, inhibit adjuvant‐induced arthritis in ratsBritish Journal of Pharmacology, 2010
- Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trialsThe Lancet, 2010
- Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statementThe Lancet Oncology, 2009
- Biphasic activity of resveratrol on indomethacin-induced gastric ulcersBiochemical and Biophysical Research Communications, 2009
- Targeting ketone drugs towards transport by the intestinal peptide transporter, PepT1Organic & Biomolecular Chemistry, 2009
- Role of nitric oxide in the gastrointestinal tractArthritis Research & Therapy, 2008
- O2-Acetoxymethyl-protected diazeniumdiolate-based NSAIDs (NONO–NSAIDs): Synthesis, nitric oxide release, and biological evaluation studiesBioorganic & Medicinal Chemistry, 2007